IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Therapeutic Advantages of Cannabimimetic Plants: Can They Substitute Medical Cannabis?

Therapeutic Advantages of Cannabimimetic Plants: Can They Substitute Medical Cannabis?
View Sample PDF
Author(s): Sasmita Mishra (Kean University, USA), Kayla V. Barreto (Kean University, USA), Michael Ezzat (Kean University, USA), Joanna Denis (Kean University, USA)and Brian W. Teasdale (Kean University, USA)
Copyright: 2023
Pages: 15
Source title: Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
Source Author(s)/Editor(s): Rana R. Zeine (Kean University, USA)and Brian W. Teasdale (Kean University, USA)
DOI: 10.4018/978-1-6684-5652-1.ch011

Purchase

View Therapeutic Advantages of Cannabimimetic Plants: Can They Substitute Medical Cannabis? on the publisher's website for pricing and purchasing information.

Abstract

Cannabis has been used by humans both for recreational and therapeutic purposes since ancient times. Among 113 different cannabinoids from Cannabis, D9-trans-tetrahydrocannabinol (D9THCs) is primarily hallucinogenic and cannabidiol (CBD) is therapeutic. The growing interest in therapeutic uses of Cannabis has created interest in several other plants which are non-cannabinoid and have secondary metabolites similar to CBD known as cannabimimetic plants. The cannabimimetic plants are currently gaining attention and can be the potential alternative to Cannabis because of certain secondary metabolites with a similar mechanism of action binding with cannabinoid receptors. For example, phytoextracts from liverworts Radula marginata, amorfrutin in Amorpha fruticose and several Rhododendron species have been reported to have cannabinoid-like properties. This chapter is providing a complete review of cannabimimetic plants focusing on botanical, biochemical, and potential therapeutic aspects.

Related Content

Yiannis Koumpouros. © 2026. 36 pages.
Antonios Archontis, Yiannis Koumpouros. © 2026. 48 pages.
R Velmurugan, J Sudarvel, Ravi Thirumalaisamy. © 2026. 24 pages.
S. Ida Evangeline. © 2026. 20 pages.
Ramya Raghavan, Srusti Shankar Moger, SaiMahima Umesh, G N Bhuvana. © 2026. 36 pages.
Tiago Manuel Horta Reis da Silva. © 2026. 32 pages.
Tiago Manuel Horta Reis da Silva. © 2026. 32 pages.
Body Bottom